IRIS
GIUNTI, DEBORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.033
Totale 3.033
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.033
Totale 3.033
Salva come PNG Salva come JPEG
Città #
Genova 2.227
Rapallo 451
Genoa 341
Bordighera 14
Totale 3.033
Salva come PNG Salva come JPEG
Nome #
Neuroprotective features of mesenchymal stem cells. 168
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 146
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 146
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 141
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 140
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 127
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 123
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 121
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 117
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 112
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis. 110
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 107
Human mesenchymal stem cells modulate B-cell functions. 102
Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 101
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 95
Restricted immune responses lead to CNS demyelination and axonal damage. 94
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 91
Dynamics of the reactivity to MBP in multiple sclerosis. 87
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. 85
racterization of the response to myelin basic protein in a non human primate model for multiple sclerosis. 84
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 83
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. 78
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 76
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 75
Mesenchimal stem cells exert beneficial effects on microglia 67
Mesenchymal stem cells exert anti-oxidant effects through the impairment of arginine metabolism 64
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 61
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 61
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 57
Mesenchymal stem cells exert their therapeutic effect by inducing microglia to acquire a neuroprotective phenotype 49
MRI and neuropathologic study of eae in the non human primate callithr1x jacchus 40
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 25
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 22
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 15
null 1
Totale 3.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.555
article - articoli 6.813
book - libri 0
conference - conferenze 1.742
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019146 0 0 0 0 0 0 0 0 0 0 81 65
2019/2020817 32 22 28 46 73 82 151 47 80 132 86 38
2020/2021212 17 15 23 24 12 8 14 30 20 20 15 14
2021/2022419 15 47 34 59 17 15 15 88 15 34 7 73
2022/2023521 42 51 4 50 104 73 4 30 86 7 63 7
2023/2024291 10 22 14 40 45 89 19 31 10 9 2 0
Totale 3.071